Consensus Orchid Pharma Limited

Equities

ORCHPHARMA

INE191A01027

Market Closed - NSE India S.E. Other stock markets 07:43:55 2024-07-12 am EDT			5-day change	1st Jan Change
1,130 ^INR	-1.97%		-1.21%	+58.56%

Jun. 28	Orchid Pharma Partners with Cipla to Launch Antibiotic Cefepime- Enmetazobactam in India	CI
Jun. 06	Orchid Pharma Gets Indian Regulator's Nod for Enmetazobactam	MT

Evolution of the average Target Price on Orchid Pharma Limited

Price target over the last 5 years

History of analyst recommendation changes

6c7f31137f3b4765f190442ee19b.27GDUrboW6TsYRKmtxwpvUxMxNLEUr9fuBGo-HeKr5o.ksPsOvWgDtWkB0Px9Spl3BsfnYKTMfgT-njelg-8y9GM-8I_0Nox54AvSw~4796c4684170d7c84a1e881178fd093d

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1,130 INR

Average target price

1,252 INR

Spread / Average Target

+10.85%

High Price Target

1,285 INR

Spread / Highest target

+13.74%

Low Price Target

1,225 INR

Spread / Lowest Target

+8.43%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar